Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis.
Saved in:
| Title: | Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. |
|---|---|
| Authors: | Lundblad MS; Novo Nordisk A/S, Søborg, Denmark, mslu@novonordisk.com., Overgaard RV, Göthberg M, Fjording MS, Watson E |
| Source: | Advances in therapy [Adv Ther] 2015 Mar; Vol. 32 (3), pp. 228-38. Date of Electronic Publication: 2015 Mar 07. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
